The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis
Abstract Background: Clinical trials investigating the use of cannabinoid drugs for the treatment of intestinal inflammation are anticipated secondary to preclinical...
Anti-Inflammatory Activity in Colon Models Is Derived from D9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts
Apr 20, 2021
Abstract Introduction: Inflammatory bowel diseases (IBDs) include Crohn’s disease, and ulcerative colitis. Cannabis sativa preparations have beneficial effects for IBD patients. However, C. sativa extracts...
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
Apr 20, 2021
Abstract Gemcitabine (GEM, 2′,2′-difluorodeoxycytidine) is currently used in advanced pancreatic adenocarcinoma, with a response rate of < 20%. The purpose...
Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene
Apr 20, 2021
Abstract The gastric cytoprotective effect of beta-caryophyllene, an anti-inflammatory sesquiterpene, was investigated in rats. The oral administration of beta-caryophyllene to...
Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases
Apr 20, 2021
Abstract Purpose of review: Complementary therapies for inflammatory bowel disease (IBD) have earned growing interest from patients and investigators alike, with...
The Role of the Endocannabinoid System in the Brain-Gut Axis
Apr 20, 2021
Abstract The actions of cannabis are mediated by receptors that are part of an endogenous cannabinoid system. The endocannabinoid system...
Cannabinoid pharmacology and therapy in gut disorders
Apr 20, 2021
Abstract Cannabis sp. and their products (marijuana, hashish…), in addition to their recreational, industrial and other uses, have a long...
Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
Apr 20, 2021
Abstract Cannabis sativa and its extracts have been used for centuries, both medicinally and recreationally. There is accumulating evidence that exogenous...
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes
Apr 20, 2021
Abstract Background Colonic dysmotility in dogs can cause different GI signs. Sometimes, histology of enterocolic biopsies does not reveal inflammatory...
Thymol modulates the endocannabinoid system and gut chemosensing of weaning pigs
Apr 20, 2021
Abstract Background The recent identification of the endocannabinoid system in the gastrointestinal tract suggests a role in controlling intestinal inflammation....
Search Our Website
Recent In The News
- CBD Oracle Interviews VCS Board and Sponsors
- New York Times: Mammals with the Munchies
- Check out this article highlighting VCS in the newest issue of “Cannabis and Tech Today.
- BREAKING NEWS! Check out this recently released statement from the U.S. Food and Drug Administration about next steps to explore potential regulatory pathways for CBD products!
- Cannabis in Veterinary Medicine | Continual Education | VIN
- Check out this conversation with VCS Founders Dr. Gary Richter, Dr. Trina Hazzah, and Charles Lozow on the importance of advocating for the safe use of cannabis in pets
- A Dose Finding Study of Cannabidiol in Dogs with Intractable Epilepsy
- Earth Buddy, Pet Calming Study – Press Release
- CALIFORNIA CANNABIS UPDATES – April 2022
- Cannabis in Veterinary Practice Multi-Expert Webinar